Fig. 9.
![Fig. 9. TF-1 cell proliferation after incubation with HTLV-2 virus. / TF-1 cells were deprived of IL-3 for 24 hours and then (A) incubated for 24 hours with CMo, Bmo, or anti–DR-BMo in the absence or in the presence of anti–GM-CSF antibodies (8 μM (μg/mL)), (B) supplemented with GM-CSF (1 nM [ng/mL]) in the absence or in the presence of anti-GM-CSF antibodies.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/99/1/10.1182_blood.v99.1.224/6/h80121939009.jpeg?Expires=1724259393&Signature=5Ej15Ior4HLRlG1E-0utEM7TxXjAWdw2w2ceUnP9-v4FSggA1AkqPDP5U~Db-dzvWO1iZqCmElEze~7sbFz06nxI3GDZyyqExxSb~O9b4h2ExRTzMaOwUumdMQrJsuWKxJah4TzJkSRyek3HMWEXNXow0RDQiaCL9CAwYZv3IYfqzM55y1ddNGNAw7gwrFUE8RziEL~18IqZR7Ges2-bzOAvbllrSFPul0C7Id9qdbzVZQwzBNX2ZshGXJSkVYPpPmle7EKChIQQcPy6BCLCspFLs3AF5RbGq-vyOeoVOWaRxv0kVOoJQIp2e8G7zmbSgZCNm1OrkcR2ldbr6INtqA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
TF-1 cell proliferation after incubation with HTLV-2 virus.
TF-1 cells were deprived of IL-3 for 24 hours and then (A) incubated for 24 hours with CMo, Bmo, or anti–DR-BMo in the absence or in the presence of anti–GM-CSF antibodies (8 μM (μg/mL)), (B) supplemented with GM-CSF (1 nM [ng/mL]) in the absence or in the presence of anti-GM-CSF antibodies.
